Abstract:Background: Diabetic retinopathy is the most common cause of blindness in industrialised nations and the incidence of diabetes is expected to rise over the next 10 years. Early treatment of proliferative diabetic retinopathy and diabetic maculopathy improves visual outcome and with effective screening, blindness could be reduced. Patients suffering from diabetes mellitus show alterations in their colour perception. Colour vision testing provides a sensitive, non-invasive method to assess macular damage in diab… Show more
“…No change in colour vision was noted at 6 months follow up. Sadiqulla et al 16 reported a red-green loss pattern prevailing then total colour blindness, Shin et al 17 reported a blue-yellow loss pattern, the same reported by Patzetal 18 andMa´ar et al 19 .…”
To assess the effects of laser photocoagulation on contrast sensitivity, visual acuity and colour vision in patients of diabetic macular edema. Methods: It is a hospital-based prospective analytical study conducted on 30 eyes of type 1 and types 2 of diabetes mellitus patients with NPDR and non-centre involved diabetic macular edema of more than 18 years of age of both the sexes for a one-year duration. Results: The majority belonged to the age group of 51-60 yrs. Males represented 60% with a peak incidence at 51-60 years and females represented 40 %. BCVA was stabilized in 63%, improved by 26% and decreased by 10%. In this study, the mean baseline contrast sensitivity was 0.49 log CS which improved significantly to o.60 log CS and 0.64 logs CS at 3 and 6 months respectively.No change in colour vision was noted at 6 months follow up Conclusion: Timely treatment of Diabetic macular edema with laser retinal photocoagulation prevents further dysfunction and salvages involved retina causing statistically significant improvement in vision and quality of life.
“…No change in colour vision was noted at 6 months follow up. Sadiqulla et al 16 reported a red-green loss pattern prevailing then total colour blindness, Shin et al 17 reported a blue-yellow loss pattern, the same reported by Patzetal 18 andMa´ar et al 19 .…”
To assess the effects of laser photocoagulation on contrast sensitivity, visual acuity and colour vision in patients of diabetic macular edema. Methods: It is a hospital-based prospective analytical study conducted on 30 eyes of type 1 and types 2 of diabetes mellitus patients with NPDR and non-centre involved diabetic macular edema of more than 18 years of age of both the sexes for a one-year duration. Results: The majority belonged to the age group of 51-60 yrs. Males represented 60% with a peak incidence at 51-60 years and females represented 40 %. BCVA was stabilized in 63%, improved by 26% and decreased by 10%. In this study, the mean baseline contrast sensitivity was 0.49 log CS which improved significantly to o.60 log CS and 0.64 logs CS at 3 and 6 months respectively.No change in colour vision was noted at 6 months follow up Conclusion: Timely treatment of Diabetic macular edema with laser retinal photocoagulation prevents further dysfunction and salvages involved retina causing statistically significant improvement in vision and quality of life.
Age, sex, refractive error, axial length, and keratometry were found to be associated with macular thickness. These factors should be taken into account when interpreting macular thickness measurements with spectral-domain OCT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.